Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLN.L Share News (SLN)

  • There is currently no data for SLN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK EXECUTIVE CHANGE SUMMARY: Silence Wants US CFO After Nasdaq Float

Thu, 08th Oct 2020 21:16

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Thursday and not separately reported by Alliance News:

----------

Silence Therapeutics PLC - novel RNA therapeutics developer - Chief Financial Officer Rob Quinn to lave company in January to take up new position. The company will look for a US-based CFO following its Nasdaq listing.

----------

Glanbia PLC - Kilkenny, Ireland-based nutrition company - John Murphy joins as non-executive director, as part of relationship with Glanbia Co-Operative Society Ltd.

----------

Jupiter US Smaller Companies PLC - investment trust - Fund Manager Robert Siddles to retire with effect April 2021. "The board would like to extend its thanks to Robert for the strong long-term performance he has delivered to shareholders over the last 19 years across a variety of market conditions," Jupiter US Smaller said.

----------

Kingfisher PLC - DIY retailer - Senior Independent Director Mark Seligman to step down from board from January 29 after nine years. Names Catherine Bradley as non-executive director, with effect November 2. Bradley is also a non-executive at budget airline easyJet PLC.

----------

KCR Residential REIT PLC - residential-focused real estate investment trust - Chair Michael Davies to step down at November 3 annual general meeting. James Thornton, currently a non-executive director, to become non-executive chair.

----------

OptiBiotix Health PLC - York-based life sciences company - Aneta Zlotkowska appointed as head of quality & operations, joining from Tesco PLC where she was lead development manager.

----------

NAHL Group PLC - wealth manager and financial advisor - Non-Executive Chair Caroline Brown resigns with immediate effect. Senior Independent Director Tim Aspinall replaces Brown.

----------

Kromek Group PLC - Sedgefield-based detection technology supplier - Names Rakesh Sharma as a non-executive director with immediate effect. Was formerly chief executive officer of Ultra Electronics Holdings PLC.

----------

Equals Group PLC - London-based payments group - Non-Executive Director John Pearson to step down with effect Friday.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
21 Aug 2020 10:21

Silence Therapeutics Files Registration Statement For ADS Listing

Silence Therapeutics Files Registration Statement For ADS Listing

Read more
16 Jul 2020 14:28

Silence Therapeutics To Develop Two More RNA Assets For Mallinckrodt

Silence Therapeutics To Develop Two More RNA Assets For Mallinckrodt

Read more
23 Jun 2020 10:14

Silence Therapeutics makes 'exceptional' year-to-date progress

(Sharecast News) - RNA therapeutics developer Silence Therapeutics said on Tuesday that it had continued to make "exceptional progress" in securing additional high-value partnerships and advancing its proprietary pipeline year-to-date.

Read more
29 May 2020 17:18

UK DIRECTOR DEALINGS SUMMARY: Moya Greene Buys GBP50,000 In easyJet

UK DIRECTOR DEALINGS SUMMARY: Moya Greene Buys GBP50,000 In easyJet

Read more
12 May 2020 15:45

Director dealings: Silence Therapeutics CFO lowers stake

(Sharecast News) - Silence Therapeutics revealed on Tuesday that chief financial officer Rob Quinn had offloaded of 89,054 ordinary shares in the AIM-listed biotechnology group.

Read more
12 May 2020 15:35

UK DIRECTOR DEALINGS SUMMARY: Silence CFO Sells GBP360,000 Worth

UK DIRECTOR DEALINGS SUMMARY: Silence CFO Sells GBP360,000 Worth

Read more
14 Apr 2020 15:21

Silence Therapeutics 2019 Loss Widens On Higher Research Costs

Silence Therapeutics 2019 Loss Widens On Higher Research Costs

Read more
9 Apr 2020 14:54

UK TRADING UPDATE SUMMARY: Naked Wines, Distil Get Bar-Closure Boost

UK TRADING UPDATE SUMMARY: Naked Wines, Distil Get Bar-Closure Boost

Read more
7 Apr 2020 16:11

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
2 Apr 2020 13:07

UK EXECUTIVE CHANGE SUMMARY: Iofina Recruits Former Oklahoma Governor

UK EXECUTIVE CHANGE SUMMARY: Iofina Recruits Former Oklahoma Governor

Read more
25 Mar 2020 10:52

UK WINNERS & LOSERS SUMMARY: Rentokil Falls After Scrapping Dividend

UK WINNERS & LOSERS SUMMARY: Rentokil Falls After Scrapping Dividend

Read more
25 Mar 2020 09:48

Silence Therapeutics Agrees Strategic Collaboration With AstraZeneca

Silence Therapeutics Agrees Strategic Collaboration With AstraZeneca

Read more
27 Jan 2020 09:36

UK BROKER RATINGS SUMMARY: Peel Hunt Cuts Ashtead And Raises DCC

UK BROKER RATINGS SUMMARY: Peel Hunt Cuts Ashtead And Raises DCC

Read more
7 Jan 2020 15:43

Silence Therapteutics inks deal with Takeda after decent year

(Sharecast News) - Serious disease therapeutics developer Silence Therapeutics updated the market on the year ended 31 December on Tuesday, reporting that it has entered into a technology evaluation agreement with Takeda to explore the potential of using its platform to generate siRNA molecules against a novel, undisclosed target discovered by Takeda.

Read more
7 Jan 2020 10:40

Silence Therapeutics Plans New US Subsidiary; Inks Deal With Takeda

Silence Therapeutics Plans New US Subsidiary; Inks Deal With Takeda

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.